Based on previous mechanism studies, the continuous activity of CIDP (i.e., a long disease course) is speculated to increase the concentration of MMP-9 and destruction of the BCB, which is a possible reason for the higher QALB in the CIDP group than in the GBS group. The gene discussed is PMP22; the disease is Guillain-Barre syndrome.